Pneumonia Vaccine – All You Need to Know

Pneumonia is a serious respiratory infection that claims millions of lives all over the world yearly. It results in serious health complications, particularly in vulnerable populations like the elderly, very young children, and those with underlying chronic health conditions. Vaccination is thus the best way to prevent pneumonia and possible complications. Everything from who needs it and how it works to the different pneumonia shots, possible risks, and effectiveness will be reviewed in this all-inclusive guide to the pneumonia vaccine.

Who Should Get the Pneumonia Vaccine?

Many groups are compelled to undergo vaccination against pneumonia because of the serious effects the disease could have on the body. Here is the breakdown of those who should get vaccinated:

1. Infants and Young Children

Children under 2 years of age are more prone to the infection. CDC has recommended vaccination of PCV13 in all children below this age. Vaccination usually follows a course of 2, 4, 6 months and a booster dose at 12-15 months.

2. Adults Aged 65 and Older

Their immune systems weaken with age, leaving them prone to infections such as pneumonia. Persons aged 65 years and above should be administered the pneumococcal polysaccharide vaccine. The CDC also recommends a PCV13 dose for all adults aged 65 years and older who have not previously received one.

3. Persons with Certain Medical Conditions

The following groups of people are at an increased risk of developing pneumonia and should be vaccinated:

People with:

• Chronic lung diseases including asthma, COPD
• Cardiovascular disease
• Diabetes
• Liver disease
• Kidney disease
• Immunocompromised state from cancer treatment, HIV, or organ transplantation among others
• Cochlear implant or cerebrospinal fluid leak

4. Smokers

Smoking is a risk factor for pneumonia since it damages the lungs and the immune system. Thus, smokers need the PPSV23 vaccine to reduce their chances of infection.

Also Read: Harmful Effects of Cigarette Smoking on Health

How It Works

The pneumonia vaccine induces an immune response against the invasion of Streptococcus pneumoniae—the common causative agent of pneumonia. When vaccinated, it will program the immune system to recognise and fight the entry of these bacteria in case they invade in the future.

Pneumococcal Conjugate Vaccine, PCV13

PCV13 contains 13 serotypes of pneumococcal, each targeting the more prevalent and serious forms of pneumonia. A small piece of the bacteria is inactivated and combined with a protein that stimulates an enhanced immune response.

Pneumococcal Polysaccharide Vaccine (PPSV23)

PPSV23 contains 23 pneumococcal strains and is recommended for adults over 65 years of age, among others. In contrast to PCV13, PPSV23 is a vaccine of purified polysaccharide isolated from sugar molecules on the surface of the bacteria.

What are the Various Types of Pneumonia Shots?

The major two types of pneumonia vaccine available today are against different strains of bacteria that can cause pneumonia. These include:

1. Pneumococcal Conjugate Vaccines

PCVs contain sugars from the outside of the pneumococcus bacteria which are linked, or conjugated, to a protein. The protein helps increase the immune response to the vaccine. There are three kinds of PCV: 

1. Prevnar13 or PCV13 
2. Vaxneuvance (PCV15) 
3. PCV20: Prevnar 20

2. Pneumococcal Polysaccharide Vaccine (PPSV)

Purified sugars are taken from the outside of pneumococcus bacteria and is included in PPSV vaccines. There is only one type of PPSV called PPSV23.

PPSV23 Vaccination is indicated for people aged 65 years and older, those who smoke, and those with various medical conditions. The vaccine contains 23 strains of pneumococcal bacteria. It is given in one dose, but some might need another dose five years after the initial vaccination.

The following table summarises the key differences between the four pneumonia vaccines, including their coverage, target age groups, and suitability for individuals with certain medical conditions.

What Are the Risks?

Like any vaccine, the pneumonia vaccine can have side effects, although they usually are mild and temporary. Common side effects of pneumonia vaccine include the following:

• Pain, redness, or swelling where the shot was given
• Fever
• Muscle aches
• Fatigue

More severe side effects can rarely happen, such as very bad allergic reactions. If you experience any of these symptoms after getting the vaccine, seek medical attention right away:

• Difficulty breathing
• Swelling of your face or throat
• Fast heartbeat
• Dizziness or weakness

One should discuss the concerns or possible risks with the health professional prior to administering the vaccine.

How Effective is the Vaccine?

 The pneumonia vaccine is hugely effective against infections caused by pneumococcal. However, it may vary in effectiveness considering factors such as age, health status, and strain types of the bacteria. Some of the important points on the effectiveness of the pneumonia vaccines are as follows:

1. Children

Studies have established that PCV13 is highly effective in preventing invasive pneumococcal disease in children. Estimations have cited a risk reduction for IPD of about 90% in vaccinated children.

2. Adults

In adults, both PCV13 and PPSV23 prevent serious pneumococcal infections. It has been established that PCV13 prevents IPD in older adults, and PPSV23 protects against more strains of pneumococcal bacteria.

3. Persons with Certain Medical Conditions

It is, therefore, very important to get vaccinated if one has a weakened immune system or any other type of chronic condition, since the pneumonia vaccine enormously brings down the potential for serious infections and complication risks in people with certain medical conditions.

Other Potential Benefits

Apart from the direct benefits in terms of protection from pneumonia, the pneumococcal vaccine confers several other benefits, including:

1. Herd Immunity

When a significant proportion of the population has been vaccinated, that helps protect those who cannot be vaccinated. This concept, known as herd immunity, decreases the overall spread of the bacteria.

2. Decreased Antibiotic Resistance

By preventing pneumococcal infections, the vaccine reduces the use of antibiotics, and thus it also fights growing antibiotic resistance. Fewer infections mean fewer opportunities for bacteria to become resistant to antibiotic treatments.

3. Economic Benefits

Preventing pneumonia through vaccination can bring about huge healthcare savings by decreasing the necessity of medical treatment, hospitalization, and chronic care. This reduces a serious economic burden on people and healthcare systems.

Conclusion

The pneumonia vaccine may just help to protect against serious respiratory infections and the possible complications that come with them. Knowing who should be vaccinated, how it works, the different shots available for pneumonia, possible risks, and effectiveness will allow you to make a proper decision about your health and well-being. Vaccination saves not only the individual but also protects public health through the reduction of pneumococcal bacteria transmission and enhancement of herd immunity.

If you or a loved one fits into one of the recommended groups, speak to your healthcare provider regarding your shot to prevent pneumonia. Keeping vaccinations updated is an essential part of health maintenance, preventing life-threatening infections. Remember, prevention is always better than cure, and the pneumonia vaccine happens to be one very powerful preventive measure that can save lives.

Get our easy-to-use Truemeds app for affordable medicines. Just upload your prescription to access both brand-name and substitute drugs. Save money on your purchases and enjoy the added convenience of free home delivery on eligible orders across India*.

Frequently Asked Questions (FAQs)

References

• Tereziu, S., & Minter, D. A. (2023, March 20). Pneumococcal Vaccine. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK507794/ 
• Mirsaeidi, M., & Schraufnagel, D. E. (2014). Pneumococcal Vaccines: Understanding Centers for Disease Control and Prevention Recommendations. Annals of the American Thoracic Society, 11(6), 980–985. https://doi.org/10.1513/annalsats.201401-042cme 
• Temime, L., Guillemot, D., & Boëlle, P. Y. (2004). Short- and Long-Term Effects of Pneumococcal Conjugate Vaccination of Children on Penicillin Resistance. Antimicrobial Agents and Chemotherapy, 48(6), 2206–2213. https://doi.org/10.1128/aac.48.6.2206-2213.2004